Targeting melanoma cell-intrinsic beta2 integrin inhibits ICAM-1-mediated tumor progression
RNA-seq (gene expression) · mouse · 20 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Mus musculus (mouse)
- Samples
- 20 samples: 6 conditions, mostly with about 4 replicates eachGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Targeting the tumor cell-intrinsic ITGB2 axis inhibits melanoma progressionMolecular cancer · 2025
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE261845_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1089202 and SRA study SRP496205. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 20 samples.
How we read this: 6 replicated groups read from 20 sample titles; they account for 20 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8152920 YUMM52-in-C57BL6WT-Cas9-control-rep1 YUMM52-in-C57BL6WT-Cas9…
- GSM8152921 YUMM52-in-C57BL6WT-Cas9-control-rep2 YUMM52-in-C57BL6WT-Cas9…
- GSM8152922 YUMM52-in-C57BL6WT-Cas9-control-rep3 YUMM52-in-C57BL6WT-Cas9…
- GSM8152923 YUMM52-in-C57BL6WT-Cas9-control-rep4 YUMM52-in-C57BL6WT-Cas9…
- GSM8152924 YUMM52-in-C57BL6WT-CD18KO-rep1 YUMM52-in-C57BL6WT-CD18…
- GSM8152925 YUMM52-in-C57BL6WT-CD18KO-rep2 YUMM52-in-C57BL6WT-CD18…
- GSM8152926 YUMM52-in-C57BL6WT-CD18KO-rep3 YUMM52-in-C57BL6WT-CD18…
- GSM8152927 YUMM52-in-ICAM1ko-Cas9-control-rep1 YUMM52-in-ICAM1ko-Cas9-…
- GSM8152928 YUMM52-in-ICAM1ko-Cas9-control-rep2 YUMM52-in-ICAM1ko-Cas9-…
- GSM8152929 YUMM52-in-ICAM1ko-Cas9-control-rep3 YUMM52-in-ICAM1ko-Cas9-…
- GSM8152930 YUMM52-in-ICAM1ko-Cas9-control-rep4 YUMM52-in-ICAM1ko-Cas9-…
- GSM8152931 YUMM52-in-ICAM1ko-CD18KO-rep1 YUMM52-in-ICAM1ko-CD18KO
- GSM8152932 YUMM52-in-ICAM1ko-CD18KO-rep2 YUMM52-in-ICAM1ko-CD18KO
- GSM8152933 YUMM52-in-NSG-Cas9-control-rep1 YUMM52-in-NSG-Cas9-cont…
- GSM8152934 YUMM52-in-NSG-Cas9-control-rep2 YUMM52-in-NSG-Cas9-cont…
- GSM8152935 YUMM52-in-NSG-Cas9-control-rep3 YUMM52-in-NSG-Cas9-cont…
- GSM8152936 YUMM52-in-NSG-Cas9-control-rep4 YUMM52-in-NSG-Cas9-cont…
- GSM8152937 YUMM52-in-NSG-CD18KO-rep1 YUMM52-in-NSG-CD18KO
- GSM8152938 YUMM52-in-NSG-CD18KO-rep2 YUMM52-in-NSG-CD18KO
- GSM8152939 YUMM52-in-NSG-CD18KO-rep3 YUMM52-in-NSG-CD18KO
- GSE333534 Targeting KRAS in a TRP53/KRAS mouse and organoid model inhibits Barrett Esophagus to Gastroesophageal Adenocarcinoma progression 20 samples shares progression, targeting, inhibits
- GSE271194 Effect of genetic modification of extracellular matrix-related genes on B16F1 melanoma progression 15 samples shares progression, melanoma
- GSE269647 Beta2 adrenergic receptor-mediated abnormal myelopoiesis drives neuroinflammation in aged patients post traumatic brain injury 12 samples shares beta2
- GSE241770 ACSS2 mediates an epigenetic pathway to regulate maternal Beta-cell adaptation and progression of gestational diabetes (scRNA-Seq) 7899 samples shares progression
- GSE327470 Temporal Uncoupling of Radial Glial Progenitor Cell Lineage Progression in Self-organizing Organoid System 292 samples shares progression
- GSE327468 Temporal Uncoupling of Radial Glial Progenitor Cell Lineage Progression in Self-organizing Organoid System – MADM-CloneSeq 287 samples shares progression
- GSE159911 “Bench-to-Bedside and Back” analysis of NAFLD model reveals common transcriptomic shifts between mouse and human during disease progression 152 samples shares progression
- GSE114456 Integrative and Quantitative Analysis of Tumor Progression Reveals Fundamental Properties of Glioblastoma 152 samples shares progression
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.